ask="N/A"
ask_size="N/A"
average_daily_volume="463106"
bid="N/A"
bid_size="N/A"
book_value="11.38"
change="+0.09"
change_from_200_day_moving_average="6.41"
change_from_50_day_moving_average="4.39"
change_from_52_week_high="-9.86"
change_From_52_week_low="30.39"
change_in_percent="+0.12%"
close="76.91"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.75"
eps_estimate_next_quarter="-1.73"
eps_estimate_next_year="-6.08"
ex_dividend_date="N/A"
float_shares="37689000"
high="78.25"
high_52_weeks="86.77"
last_trade_date="2/17/2017"
last_trade_price="76.91"
last_trade_size="55280"
last_trade_time="4:00pm"
low="72.88"
low_52_weeks="46.52"
market_capitalization="3.14B"
moving_average_200_day="70.50"
moving_average_50_day="72.52"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="78.25"
pe_ratio="N/A"
peg_ratio="-0.38"
percent_change_from_200_day_moving_average="+9.09%"
percent_change_from_50_day_moving_average="+6.05%"
percent_change_from_52_week_high="-11.36%"
percent_change_from_52_week_low="+65.33%"
previous_close="76.82"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.75"
price_per_sales="24521.78"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="15.47"
stock_exchange="NMS"
symbol="RARE"
volume="708333"
weeks_range_52="46.52 - 86.77"
